Schizophrenia News and Research

Latest Schizophrenia News and Research

Gene variant that may increase the risk of late-onset Alzheimer's disease

Researchers from the MassGeneral Institute for Neurodegenerative Disorders (MIND) have identified a gene variant that may increase the risk of late-onset Alzheimer's disease.

2 Mar 2005

Dramatic evidence of how psychiatric disorders are underdiagnosed in hospital emergency departments

New research offers dramatic evidence of how psychiatric disorders are underdiagnosed in hospital emergency departments, affecting an increasing number of Americans who rely on such facilities for much of their primary health care needs.

23 Feb 2005

Cannabis use may increase risk of stroke

Regular users of cannabis could be putting themselves at risk of stroke, while they are still young, indicates a case report, published in the Journal of Neurology Neurosurgery and Psychiatry.

20 Feb 2005

Schizophrenia may arise from a single genetic defect

Researchers have long puzzled over the apparently multiple causes of complex developmental disorders such as schizophrenia. Individuals seem to be predisposed to the disease by a tragic, mysterious combination of genetics, prenatal trauma, viral infection, and early experience.

16 Feb 2005

Achieva 3T MR Scanner launched officially launched

The first 'next generation' MRI (magnetic resonance imaging) body scanner in the world will be officially launched at Hope Hospital later this week (Friday 18th February).

15 Feb 2005

Research confirms how early-life events shape later physiology

Underscoring the value of good prenatal care, new research suggests that early infection may create a cognitive vulnerability that appears later during stress on the immune system.

8 Feb 2005

Organon’s compound, Org 24448, selected to test efficacy of cognitive dysfunction in schizophrenia

The National Institute of Mental Health (NIMH) sponsored network called Treatment Units for Research on Neurocognition in Schizophrenia (TURNS) has selected Organon’s compound, Org 24448, to undergo testing as part of its effort to facilitate the development of medications to enhance cognition in patients with schizophrenia.

24 Jan 2005

Psychiatric disorders detected using blood test

ChondroGene Limited reported today that a paper entitled "Assessing the Validity of Blood- Based Gene Expression Profiles for the Classification of Schizophrenia and Bipolar Disorder: A preliminary Report" is available online on the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics' website.

19 Jan 2005

Memory problems could be a clue to psychosis

University of Melbourne researchers have identified a variety of intellectual impairments, such as difficulties young people have in remembering new information, that could be a marker for later psychosis.

18 Jan 2005

Study identifies potentially valuable applications for new drug Nifrolidine

Along with aiding efforts to study addicted smokers, a new drug that attaches only to areas of the brain that have been implicated in nicotine addiction may help studies of people battling other disorders such as Alzheimer’s disease and schizophrenia.

12 Jan 2005

Functional magnetic resonance imaging helps visualize the human brain as a massive, interacting, complex network

A team headed by scientists at Northwestern University, using functional magnetic resonance imaging (fMRI), has shown how to visualize the human brain as a massive, interacting, complex network governed by a few underlying dynamic principles.

5 Jan 2005

Sméagol, a 587 year old, hobbit-like male of no fixed abode had issues

The mental health of Tolkien's character Gollum has long been a mystery to Lord of the Rings fans, who have argued the nature of Gollum's ‘mental illness' on over 1300 websites –did he have schizophrenia or was he suffering from multiple personality disorder? UCL scientists now diagnose the famous character in a paper published in this week's British Medical Journal (BMJ).

21 Dec 2004

Genetic markers implicated in fatal side effects of schizophrenia drug

Genaissance Pharmaceuticals today announced results from its CARING (Clozapine and Agranulocytosis Relationships Investigated by Genetics) study, reporting the discovery of genetic markers that the Company believes predict who is at risk of developing clozapine-induced agranulocytosis

20 Dec 2004

Neurobiologists distinguish in unprecedented detail the patterns of brain activity

Using hairlike microelectrodes and computer analysis, neurobiologists at Duke University Medical Center have demonstrated that they can see the detailed instant-to-instant electrical "brainscape" of neural activity across a living brain.

8 Dec 2004

A new study will research the best way to treat women with psychosis who then become pregnant

The national study will look at the best clinical practice for treating pregnant women with schizophrenia and other psychosis by setting up an Australian wide database of pregnant women with schizophrenia and related disorders. The study will follow the woman and her baby during pregnancy up to the first year of the baby's life.

29 Nov 2004

New class of drugs to repair psychiatric disorders

“Smart” drugs capable of targeting specific brain cells to control psychiatric disorders such as autism and schizophrenia may be ready for early clinical trials within three years, with the launch of a $1.5 million project to take place at the Brain Research Centre (BRC)

29 Nov 2004

Research looks at the relationship between fetal health during pregnancy and later development of the brain

A new Canada Research Chair (CRC) at The University of Western Ontario is studying the relationship between fetal health during pregnancy and later development of the brain.

24 Nov 2004

Large increase in male mentally ill drug abusers

The amount of mentally ill male drug abusers has increased by more than 79% in five years across England and Wales, finds research in the Journal of Epidemiology and Community Health.

16 Nov 2004

Shp2 protein plays a critical role in obesity

A team of researchers led by The Burnham Institute's Gen-Sheng Feng, Ph.D. has discovered that a protein called Shp2 plays a critical role in obesity.

11 Nov 2004

Scientists have identified a fault in the brain waves of schizophrenics that may explain their hallucinations and disturbed thinking

The researchers studied the brain waves of normal and schizophrenic patients as they responded to images. Those with the disorder showed no electrical activity in a certain frequency-the “gamma” range, from 30 to 100 brain waves per second-that healthy brain cells use to exchange information about the environment and form mental impressions.

9 Nov 2004